CompoAtlas

EU YAN SANG NING SHEN PILLS (SMALL PILLS)

EU YAN SANG NING SHEN PILLS (SMALL PILLS) : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Codonopsis pilosulaCodonopsis pilosula[648.80 mg,10000 mg]Not identified
Lycium barbarumLycium barbarum[405.50 mg,10000 mg]Not identified
Dioscorea oppositaDioscorea opposita[648.80 mg,10000 mg]Not identified
Cuscuta chinensisCuscuta chinensis[324.40 mg,10000 mg]Not identified
Rehmannia glutinosaRehmannia glutinosa[648.80 mg,10000 mg]Not identified
Ziziphus jujubaZiziphus jujuba[486.60 mg,10000 mg]Not identified
Citrus reticulataCitrus reticulata[81.10 mg,10000 mg]Not identified
Poria cocosPoria cocos[324.40 mg,10000 mg]Not identified
Salvia miltiorrhizaSalvia miltiorrhiza[81.10 mg,10000 mg]Not identified
Atractylodes macrocephalaAtractylodes macrocephala[324.40 mg,10000 mg]Not identified
Schisandra chinensisSchisandra chinensis[243.30 mg,10000 mg]Not identified
Paeonia lactifloraPaeonia lactiflora[243.30 mg,10000 mg]Not identified
Euryale feroxEuryale ferox[648.80 mg,10000 mg]Not identified
Euphoria longanEuphoria longan[648.80 mg,10000 mg]Not identified
Ophiopogon japonicusOphiopogon japonicus[162.20 mg,10000 mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[243.30 mg,10000 mg]Not identified
Nelumbo nuciferaNelumbo nucifera[648.80 mg,10000 mg]Not identified
Ligustrum lucidumLigustrum lucidum[486.60 mg,10000 mg]Not identified
Ziziphus spinosaZiziphus spinosa[405.50 mg,10000 mg]Not identified
Astragalus complanatusAstragalus complanatus[405.50 mg,10000 mg]Not identified
HoneyHoney[1890 mg,10000 mg]Miel

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL19076066T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
WENG LI SDN. BHD.
Manufacturer
WENG LI SDN. BHD.
Registration period starting
2024-07-16
Published validity end
2029-07-16

Original register data

View published fields and their variants
Active ingredients
Codonopsis pilosula[648.80 mg,10000 mg],Lycium barbarum[405.50 mg,10000 mg],Dioscorea opposita[648.80 mg,10000 mg],Cuscuta chinensis[324.40 mg,10000 mg],Rehmannia glutinosa[648.80 mg,10000 mg],Ziziphus jujuba[486.60 mg,10000 mg],Citrus reticulata[81.10 mg,10000 mg],Poria cocos[324.40 mg,10000 mg],Salvia miltiorrhiza[81.10 mg,10000 mg],Atractylodes macrocephala[324.40 mg,10000 mg],Schisandra chinensis[243.30 mg,10000 mg],Paeonia lactiflora[243.30 mg,10000 mg],Euryale ferox[648.80 mg,10000 mg],Euphoria longan[648.80 mg,10000 mg],Ophiopogon japonicus[162.20 mg,10000 mg],Glycyrrhiza uralensis[243.30 mg,10000 mg],Nelumbo nucifera[648.80 mg,10000 mg],Ligustrum lucidum[486.60 mg,10000 mg],Ziziphus spinosa[405.50 mg,10000 mg],Astragalus complanatus[405.50 mg,10000 mg],Honey[1890 mg,10000 mg]
Valid until
2029-07-16
Registration date
2024-07-16
Published description
NATURAL PRODUCT
Licence holder
WENG LI SDN. BHD.
Producer
WENG LI SDN. BHD.
Published name
EU YAN SANG NING SHEN PILLS (SMALL PILLS)
Published reference
201811081348T
Registration number
MAL19076066T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL19076066T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    Sources cited by Health Canada (1)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    Sources cited by Health Canada (2)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “EU YAN SANG NING SHEN PILLS (SMALL PILLS)”, https://compoatlas.com/en/supplements/malaysia/MAL19076066T-eu-yan-sang-ning-shen-pills-small-pills, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line